Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The Enterobacteriaceae are a family of Gram-negative bacteria that include commensal organisms as well as primary and opportunistic pathogens that are among the leading causes of morbidity and mortality worldwide. Although Enterobacteriaceae often comprise less than 1% of a healthy intestine's microbiota, some of these organisms can bloom in the inflamed gut; expansion of enterobacteria is a hallmark of microbial imbalance known as dysbiosis. Microcins are small secreted proteins that possess antimicrobial activity in vitro, but whose role in vivo has been unclear. Here we demonstrate that microcins enable the probiotic bacterium Escherichia coli Nissle 1917 (EcN) to limit the expansion of competing Enterobacteriaceae (including pathogens and pathobionts) during intestinal inflammation. Microcin-producing EcN limits the growth of competitors in the inflamed intestine, including commensal E. coli, adherent-invasive E. coli and the related pathogen Salmonella enterica. Moreover, only therapeutic administration of the wild-type, microcin-producing EcN to mice previously infected with S. enterica substantially reduced intestinal colonization by the pathogen. Our work provides the first evidence that microcins mediate inter- and intraspecies competition among the Enterobacteriaceae in the inflamed gut. Moreover, we show that microcins can act as narrow-spectrum therapeutics to inhibit enteric pathogens and reduce enterobacterial blooms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, E. coli strain Nissle targets the uptake of siderophore‐bound iron by pathogenic Enterobacteriaceae – such as Salmonella – by secreting microcins, small anti‐bacterial molecules that bind bacteria via their catecholate siderophore receptors. 170”
From The battle for iron in enteric infections (2020) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Gut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut
Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron
Deriu, E., Liu, J. Z., Pezeshki, M., Edwards, R. A., Ochoa, R. J., Contreras, H., Libby, S. J., Fang, F. C., & Raffatellu, M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.007 · Cited by 550
Self-citationRaffatellu, M., George, M. D., Akiyama, Y., Hornsby, M. J., Nuccio, S.-P., Paixao, T. A., Butler, B. P., Chu, H., Santos, R. L., Berger, T., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.011 · Cited by 525
Self-citation
Cited by
Items 201–300 of 550
Early development of the skin microbiome: therapeutic opportunities
Casterline, B. W., & Paller, A. S. (2020) · Pediatric Research · doi:10.1038/s41390-020-01146-2 · Cited by 41
Enterococcal bacteremia in mice is prevented by oral administration of probiotic Bacillus spores
Piewngam, P., Chiou, J., Ling, J., Liu, R., Pupa, P., Zheng, Y., & Otto, M. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf4692 · Cited by 36
Probiotics in health and disease: fooling Mother Nature?
Abid, M. B., & Koh, C. J. (2019) · Infection · doi:10.1007/s15010-019-01351-0 · Cited by 39
Melatonin improves the homeostasis of mice gut microbiota rhythm caused by sleep restriction
Li, W., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105121 · Cited by 38
Dynamic network modeling of gut microbiota during Alzheimer’s disease progression in mice
Li, Y., Chen, Y., Fan, Y., Chen, Y., & Chen, Y. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2172672 · Cited by 40
“For example, microcins produced by Escherichia coli could repress some Enterobacteriaceae species.(59) On the other hand, bacteriophages also have potential to eliminate specific bacteria.”
BackgroundHarnessing Iron Acquisition Machinery to Target Enterobacteriaceae
Sargun, A., Gerner, R. R., Raffatellu, M., & Nolan, E. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa440 · Cited by 38
“Moreover, consistent with the prediction that microcins only target Enterobacteriaceae, microcin production had no broad effects on the gut microbiota composition [6].”
BackgroundResultSelf-citationIntestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children
Torun, A., Hupalowska, A., Trzonkowski, P., Kierkuś, J., & Pyrzyńska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642166 · Cited by 42
Pathogen-pathogen interactions during co-infections
Ferreira, R. B. R., Antunes, L. C. M., & Sal‐Man, N. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf104 · Cited by 39
“Commensal E. coli was shown to produce small bacteriocins,such as the microcin H47 toxin, that limit Salmonella enterica serovar Typhimurium and E. coli pathogenesis toward host cells [67, 68].”
Microbial approaches for targeting antibiotic‐resistant bacteria
Wong, W. F., & Santiago, M. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12783 · Cited by 34
“In fact, co-culture of some commensal and pathogenic strains results in the direct killing of the pathogen through the production of secreted molecules like bacteriocins (Gilmore et al., 2015; Gaca and Gilmore, 2016; Sassone-Corsi et al., 2016).”
BackgroundWong‐Chew, R. M., de Castro, J.-A. A., Morelli, L., Perez, M. I., & Özen, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2085559 · Cited by 38
Bacteriocins: antibiotics in the age of the microbiome
Egan, K. M., Ross, R. P., & Hill, C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20160015 · Cited by 40
Genetically engineered bacteria as inflammatory bowel disease therapeutics
Zou, Z., Zhang, X.-P., Zhang, Q., Yin, B., Zhou, Y. Q., & Ye, B. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100167 · Cited by 40
“EcN has inherent anti-inflammatory and intestinal flora regulatory characteristics and is marketed as the main component of Mutaflor® for the treatment of IBD [ 45–47 ].”
Lee, S., Silverman, N. S., & Gao, F. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.09.001 · Cited by 38
Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products
Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 37
Colicin FY inhibits pathogenic Yersinia enterocolitica in mice
Bosák, J., Micenková, L., Hrala, M., Pomorská, K., Bosakova, M. K., Krejčí, P., Göpfert, E., Faldyna, M., & Šmajs, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-30729-7 · Cited by 36
Jacob, E. M., Borah, A., Pillai, S. C., & Kumar, D. S. (2020) · Nanomaterials · doi:10.3390/nano10122460 · Cited by 33
“The production of microcin’s by the E. coli strain Nissle 1917 can reduce intestinal colonization by Salmonella enterica serovar Typhimurium [49].”
BackgroundBasile, A., Heinken, A., Hertel, J., Smarr, L. L., Li, W., Treu, L., Valle, G., Campanaro, S., & Thiele, I. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2226921 · Cited by 34
“L-serine has been shown to interact with the gut microbiome and is known to elicit the secretion of antimicrobial molecules, such as bacteriocins.(59) This amino acid is mainly produced by species of the Dialister genus and its importance will be discussed in the following paragraph.”
BackgroundAltered Gut Microbiota in Patients With Peutz-Jeghers Syndrome
Wan, S., Huang, G., Wang, J.-X., Tian, L., Zuo, X., Li, Y., & Yu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.881508 · Cited by 32
“Enterobacteriaceae, which includes commensal organisms, primary pathogens, and opportunistic pathogens, are often abundant in the inflamed gut (Sassone-Corsi et al., 2016).”
BackgroundPadhi, S., Sarkar, P., Sahoo, D., & Rai, A. K. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13313 · Cited by 36
“66 They have been known to govern certain metabolic pathways thereby regulating the levels of pro-and anti-in fl ammatory cytokines.”
Principles of gut microbiota assembly
Chávez‐Arroyo, A., Radlinski, L. C., & Bäumler, A. J. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.02.014 · Cited by 38
Davies, M. A., Galazzo, G., van Hattem, J. M., Arcilla, M. S., Melles∗, D. C., de Jong, M. D., Schultsz, C., Wolffs, P. F. G., McNally, A., van Schaik, W., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2060676 · Cited by 37
Xu, K., Guo, Y., Wang, Y., Ren, Y., Low, V., Cho, S., Ping, L., Peng, K., Li, X., Qiu, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13760 · Cited by 35
Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains
Steimle, A., Menz, S., Bender, A., Ball, B., Weber, A. N. R., Hagemann, T., Lange, A., Maerz, J. K., Parusel, R., Michaelis, L., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000334 · Cited by 41
“EcN provides different beneficial properties such as (1) the formation of biofilms [12] leading to the production of defensins [12,13], (2) strengthening of tight junctions within the intestinal epithelium [14], (3) direct antimicrobial effects via secretion of bacteriocins and microcins [15], and (4) direct interacti…”
BackgroundNext-generation probiotics and engineered BEVs for precision therapeutics in osteoporosis
Wei, J., Ding, W., Song, K., Zhang, Y., Luo, Q., & Qi, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1581971 · Cited by 31
Said, L. B., Emond-Rhéault, J.-G., Soltani, S., Telhig, S., Zirah, S., Rebuffat, S., Diarra, M. S., Goodridge, L. D., Lévesque, R. C., & Fliss, I. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15045 · Cited by 33
Synbiotics in Animal Health and Production
Malik, J. K., Prakash, A., Srivastava, A. K., & Gupta, R. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_20 · Cited by 29
Microbiome Therapeutics: A Path Toward Sustainable Healthcare
Kumar, T., & Chauhan, N. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00010-3 · Cited by 30
Gao, K.-X., Peng, X., Wang, J., Wang, Y., Pei, K., Meng, X.-L., Zhang, S.-S., Hu, M.-B., & Liu, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131391 · Cited by 32
Cherrak, Y., Salazar, M. A., Yilmaz, K., Kreuzer, M., & Hardt, W. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002616 · Cited by 34
Iron at the crossroads of host–microbiome interactions in health and disease
Choi, G., & Bessman, N. J. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02001-y · Cited by 36
“Moreover, small antimicrobial proteins, microcins, secreted by E. coli Nissle 1917 in an iron-limited condition, restrict the expansion of Enterobacteriaceae, which includes competing commensals, pathobionts and pathogens 65 .”
Cocultivation of Anaerobic Fungi with Rumen Bacteria Establishes an Antagonistic Relationship
Swift, C. L., Louie, K., Bowen, B. P., Hooker, C. A., Solomon, K., Singan, V. R., Daum, C. G., Pennacchio, C., Barry, K., Shutthanandan, V. S., et al. (2021) · mBio · doi:10.1128/mbio.01442-21 · Cited by 32
“microbial diversity (5, 6), protect against invasion by pathogens (7), and drive genome evo-”
BackgroundExpanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology
Ba, F., Zhang, Y., Ji, X., Liu, W., Ling, S., & Li, J. (2023) · Biotechnology Journal · doi:10.1002/biot.202300327 · Cited by 33
Recent Advances in the Nanoshells Approach for Encapsulation of Single Probiotics
Chen, C., & Zhu, Z. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s419897 · Cited by 27
Mao, L., Gao, B., Chang, H., & Shen, H. (2024) · Metabolites · doi:10.3390/metabo14010043 · Cited by 27
Kroon, S., Malcic, D., Weidert, L., Bircher, L., Boldt, L., Christen, P., Kiefer, P., Sintsova, A., Nguyen, B. D., Barthel, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57979-0 · Cited by 33
van der Hooft, J. J. J., Goldstone, R. J., Harris, S., Burgess, K. E., & Smith, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00252 · Cited by 39
Sibinelli‐Sousa, S., Silva, A. L. D. A., Hespanhol, J. T., & Bayer‐Santos, E. (2021) · FEBS Journal · doi:10.1111/febs.16211 · Cited by 31
Bacterial Protein Mimetic of Peptide Hormone as a New Class of Protein- based Drugs
Fetissov, S. O., Legrand, R., & Lucas, N. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171005110620 · Cited by 28
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria
Ding, W., Cheng, Y., Liu, X., Zhu, Z., Wu, L., Gao, J., Lei, W., Li, Y., Zhou, X., Wu, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563450 · Cited by 30
Drider, D. (2021) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-021-09843-y · Cited by 28
Ansari, M. H. R., Saher, S., Parveen, R., Khan, W., Khan, I. A., & Ahmad, S. (2022) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2022.03.005 · Cited by 30
An emerging field: Post‐translational modification in microbiome
Duan, H., Zhang, X., & Figeys, D. (2022) · PROTEOMICS · doi:10.1002/pmic.202100389 · Cited by 34
Cause or effect? The spatial organization of pathogens and the gut microbiota in disease
Nguyen, J., Pepin, D. M., & Tropini, C. (2021) · Microbes and Infection · doi:10.1016/j.micinf.2021.104815 · Cited by 29
Wende, M., Osbelt, L., Eisenhard, L., Lesker, T. R., Damaris, B. F., Mutukumarasamy, U., Bielecka, A., Almási, É. D. H., Winter, K. A., Schauer, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61327-7 · Cited by 25
“Typhimurium 26 or E. coli 43,44 via multiple mechanisms including microcin and siderophore production.”
Ohno, M., Hasegawa, M., Hayashi, A., Caballero-Flores, G. G., Alteri, C. J., Lawley, T. D., Kamada, N., Núñez, G., & Inohara, N. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008928 · Cited by 26
“Nissle 1917 produces microcins H47 and M which has been suggested to mediate its ability to outcompete other bacteria and reduce colitis [40, 41].”
Tradeoffs and constraints on the evolution of tailocins
Backman, T., Burbano, H. A., & Karasov, T. L. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.04.001 · Cited by 27
He, J., Li, C., Cui, P., & Wang, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02049 · Cited by 29
“%) strains may be due to the prevalence of multiple mobile elements in both bacteria, which was confirmed in previous studies (Beutlich et al., 2011; Murgia et al., 2015; Schultz et al., 2015; Lei et al., 2018).”
ResultZou, C., Chen, Y., Li, H., Li, W., Wei, J., Li, Z., Wang, X., Chen, T., & Huang, H. H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857869 · Cited by 24
Özçam, M., Oh, J., Tocmo, R., Acharya, D. D., Zhang, S., Astmann, T. J., Heggen, M., Ruiz-Ramírez, S., Li, F., Cheng, C. C., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.03.033 · Cited by 26
Heinzinger, L. R., Pugh, A. R., Wagner, J. A., & Otto, M. J. (2023) · Antibiotics · doi:10.3390/antibiotics12081256 · Cited by 26
Infection therapy: the problem of drug resistance – and possible solutions
Brüssow, H. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12777 · Cited by 27
“thus represent a possible treatment mode for enterobacterial colitis (Sassone-Corsi et al., 2016).”
BackgroundTosR-Mediated Regulation of Adhesins and Biofilm Formation in Uropathogenic Escherichia coli
Luterbach, C., Forsyth, V. S., Engstrom, M. D., & Mobley, H. L. T. (2018) · mSphere · doi:10.1128/msphere.00222-18 · Cited by 25
Bosák, J., Hrala, M., Micenková, L., & Šmajs, D. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1816824 · Cited by 26
“human probiotics (reviewed in [117]), have a good colonization capacity of human gut, belong to phylogroup B2, and both of these probiotic strains produce bacteriocins [73,118,119].”
BackgroundInfluentialNew Insights Into DAEC and EAEC Pathogenesis and Phylogeny
Meza-Segura, M., Zaidi, M. B., de León, A. V., Morán-García, N., Martínez‐Romero, E., Nataro, J. P., & Estrada‐García, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572951 · Cited by 28
Within-host bacterial evolution and the emergence of pathogenicity
Tonkin‐Hill, G. Q., Ruis, C., Bentley, S. D., Lythgoe, K., & Bryant, J. M. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02036-1 · Cited by 33
“For instance, although the probiotic strain Escherichia coli Nissle can inhibit pathogenic Enterobacteriaceae via bacteriocin production 21 , this density-dependent trait suggests that abundant resident bacteria may outcompete initially low-frequency probiotic strains 22 .”
Ye, J., Erland, L. A. E., Gill, S. K., Bishop, S. L., Verdugo‐Meza, A., Murch, S. J., & Gibson, D. L. (2021) · Biomolecules · doi:10.3390/biom11050738 · Cited by 25
“EcN inhibits pathogenic bacteria colonization by secreting antimicrobial peptides [18], outcompeting pathogens for nutrient uptake [19], and displaying anti-inflammatory effects with reduced expression of colonic COX-2 (cyclooxygenase-2) and IFN-γ (interferon-γ) [20,21].”
BackgroundMicroenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease
Lopez, L. R., Ahn, J.-H., Alves, T., & Arthur, J. C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934619 · Cited by 25
He, L., Tang, W., Huang, L., Zhou, W., Huang, S., Zou, L., Yuan, L., Men, D., Chen, S., & Hu, Y. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10449 · Cited by 24
“Typhimurium LT2 under iron-rich or iron-limiting conditions was performed as previously described.(70)”
MethodA Modern-World View of Host–Microbiota–Pathogen Interactions
Tan, C. Y., Ramirez, Z. E., & Surana, N. K. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100215 · Cited by 24
Geervliet, M., de Vries, H., Jansen, C. A., Rutten, V. P. M. G., van Hees, H. M. J., Wen, C., Skovgaard, K., Antonello, G., Savelkoul, H. F. J., Smidt, H., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.842437 · Cited by 24
Cao, Z., Liu, R., Wang, C., Lin, S., Wang, L., & Pang, Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c08780 · Cited by 23
Desiderato, C. K., Sachsenmaier, S., Ovchinnikov, K. V., Stohr, J., Jacksch, S., Desef, D. N., Crauwels, P., Egert, M., Diep, D. B., Goldbeck, O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168615 · Cited by 26
Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions
Srivastava, R., & Lesser, C. F. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70057 · Cited by 25
Next-generation probiotics: an outlook into current applications and future developments
Kern, L., Tofield, A., Frame, J., & Elinav, E. (2026) · Nature Reviews Microbiology · doi:10.1038/s41579-026-01311-0 · Cited by 31
“Escherichia coli Nissle strain, for example, produces bacteriocins, microcins and other competitive molecules that actively inhibit the establishment of other competing strains 58 .”
Evidence for Widespread Class II Microcins in Enterobacterales Genomes
Cole, T. J., Parker, J. K., Feller, A. L., Wilke, C. O., & Davies, B. W. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01486-22 · Cited by 23
“(18–20), are capable of modulating bacterial communities in vivo (21, 22), and may”
BackgroundABC-HuMi: the Atlas of Biosynthetic Gene Clusters in the Human Microbiome
Hirsch, P., Tagirdzhanov, A., Kushnareva, A., Olkhovskii, I., Graf, S., Schmartz, G. P., Hegemann, J. D., Bozhüyük, K. A. J., Müller, R., Keller, A., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1086 · Cited by 25
Regulatory functions and mechanisms of human microbiota in infectious diseases
Fang, Y., Lei, Z., Zhang, L., Liu, C. H., & Chai, Q. (2024) · hLife · doi:10.1016/j.hlife.2024.03.004 · Cited by 22
Mechanisms of intestinal dysbiosis: new insights into tuft cell functions
Coutry, N., Gasmi, I., Herbert, F., & Jay, P. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2379624 · Cited by 23
Inulin impacts tumorigenesis promotion by colibactin-producing Escherichia coli in ApcMin/+ mice
Oliero, M., Hajjar, R., Cuisiniere, T., Fragoso, G., Calvé, A., & Santos, M. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1067505 · Cited by 19
“, 2013) and to limit the growth of related competitors, including pathobionts from the Enterobacteriaceae family, through the release of small antimicrobial molecules called microcins (Sassone-Corsi et al., 2016).”
BackgroundBacterial warfare is associated with virulence and antimicrobial resistance
Sharp, C., & Foster, K. R. (2025) · Nature Communications · doi:10.1038/s41467-025-64363-5 · Cited by 22
Ma, Y., Zhang, Q., Liu, W., Chen, Z., Zou, C., Fu, L., Wang, Y., & Liu, Y. (2021) · Marine Drugs · doi:10.3390/md19020080 · Cited by 22
“Enterobacteriaceae account for less than 1% in healthy intestines but increase significantly in inflamed intestines, which is a sign of intestinal flora imbalance [56].”
BackgroundWang, Y. X., Huang, H. B., Dong, Y. H., Li, Z., Liu, F., & Du, Y. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13175 · Cited by 19
Kim, H. J., Jang, J. H., Jung, I. Y., Kim, H. R., & Cho, J. H. (2023) · Biomedicines · doi:10.3390/biomedicines11102645 · Cited by 19
Baindara, P., & Mandal, S. M. (2023) · Antibiotics · doi:10.3390/antibiotics12121732 · Cited by 20
“…by a probiotic bacterium Escherichia coli Nissle 1917 (EcN) can regulate inter-and intra-species competition among the Enterobacteriaceae and other related pathogens in the inflamed gut environment and are suggested as potential narrow-spectrum therapeutic agents against enteric pathogens [29].”
BackgroundSantiago, M., 1 Finch Therapeutics, 2. I. B. R., Eysenbach, L. M., Allegretti, J. R., Aroniadis, O. C., Brandt, L. J., Fischer, M., Grinspan, A. M., Kelly, C. R., Morrow, C. D., et al. (2019) · AIMS Microbiology · doi:10.3934/microbiol.2019.1.1 · Cited by 20
Hung, Y., Lee, C., Lee, J., Tsai, P.-J., Hsueh, P., & Ko, W. (2021) · Antibiotics · doi:10.3390/antibiotics10091086 · Cited by 22
The role of gut microbiota in infectious diseases
Cai, Y., Chen, L., Zhang, S., Zeng, L., & Zeng, G. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1551 · Cited by 19
Effect of Probiotic-Fortified Infant Formula on Infant Gut Health and Microbiota Modulation
Eor, J. Y., Lee, C. S., Moon, S. H., Cheon, J. Y., Pathiraja, D., Park, B., Shin, M. J., Kim, J.-Y., Kim, S., Noh, Y., et al. (2023) · Food Science of Animal Resources · doi:10.5851/kosfa.2023.e26 · Cited by 19
Forsyth, J. H., Barron, N. L., Scott, L., Watson, B. N. J., Chisnall, M. A. W., Meaden, S., van Houte, S., & Raymond, B. (2023) · Microbiology · doi:10.1099/mic.0.001352 · Cited by 23
“Here, competition for nutrients such as iron, or antagonism based on the production of antimicrobial peptides such as bacteriocins, is the basis for displacement; both are believed to contribute to the efficacy of the probiotic strain E. coli Nissle [34, 35].”
Yu, L., Li, W., Zeng, Z., Han, Y., Chen, Q., Dong, X., Wang, Z., Feng, S., & Cao, W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01784-23 · Cited by 18
“The infection and pathology of mice after treatment were determined by assessing the presence of blood in the stool and degree of intestinal lesions after dissection I (9, 11).”
BackgroundKuang, M., Yu, H., Qiao, S., Huang, T., Zhang, J., Mingchao, S., Shi, X., & Chen, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413580 · Cited by 21
Tissue macrophages as mediators of a healthy relationship with gut commensal microbiota
Nakagaki, B. N., Vieira, A. T., Rezende, R. M., David, B. A., & Menezes, G. B. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.017 · Cited by 19
“production of bacteriocins [44]; and production of short chain fatty acids (acetate or butyrate), which alter the pH by inhibiting the growth of certain”
BackgroundExport of Diverse and Bioactive Small Proteins through a Type I Secretion System
Kim, S., Parker, J. K., González-Magaldi, M., Telford, M. S., Leahy, D. J., & Davies, B. W. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.00335-23 · Cited by 20
Akritidou, T., Akkermans, S., Smet, C., Gaspari, S., Sharma, C., Matthews, E., & van Impe, J. F. M. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113292 · Cited by 23
Probiotic fengycins dis(Agr)ee with Staphylococcus aureus colonization
Chung, L. K., & Raffatellu, M. (2019) · Cell Research · doi:10.1038/s41422-018-0126-3 · Cited by 17
Self-citationBao, Y., Verdegaal, A. A., Anderson, B. W., Barry, N. A., He, J. J., Gao, X., & Goodman, A. L. (2021) · mBio · doi:10.1128/mbio.00656-21 · Cited by 17
“Both contact-dependent and diffusible toxins can limit the expansion of competing commensals and pathogens in vivo (10, 14, 15).”
BackgroundGuo, C., Wang, K.-K. A., & Nolan, E. M. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00686 · Cited by 16
Towards Understanding Tumour Colonisation by Probiotic Bacterium E. coli Nissle 1917
Radford, G., Vrbanac, L., de Nys, R., Worthley, D. L., Wright, J. A., Hasty, J., & Woods, S. L. (2024) · Cancers · doi:10.3390/cancers16172971 · Cited by 21
“These fitness properties enable EcN to withstand inflammation and outcompete other enteric pathogens, ultimately preventing inflammation [25,26] and maintaining intestinal tight junction integrity, potentially through the deployment of outer membrane vesicles, as shown in vitro [27].”
BackgroundGut microbiota metabolically mediate intestinal helminth infection in zebrafish
Hammer, A. J., Gaulke, C. A., García‐Jaramillo, M., Leong, C., Morré, J. T., Sieler, M. J., Stevens, J. F., Jiang, Y., Maier, C. S., Kent, M. L., et al. (2024) · mSystems · doi:10.1128/msystems.00545-24 · Cited by 17
“For instance, bacteria can alter the protective integrity of mucosal barriers (20–23), drive peristaltic activity (24, 25), and produce inhibitory antibiotic compounds that limit pathogen and parasite survival (19, 26–28).”
BackgroundDeciphering the Role of Colicins during Colonization of the Mammalian Gut by Commensal E. coli
Samuels, A. N., Roggiani, M., Smith, K. A., Zhu, J., Goulian, M., & Kohli, R. M. (2020) · Microorganisms · doi:10.3390/microorganisms8050664 · Cited by 20
“coli laboratory strains are not natural colonizers of the murine gut and, consequently, in the absence of streptomycin or dysbiosis, most strains poorly and transiently colonize the healthy murine gut [23,26,27].”
BackgroundMazurek-Popczyk, J., Pisarska, J., Bok, E., & Baldy-Chudzik, K. (2020) · Antibiotics · doi:10.3390/antibiotics9070411 · Cited by 18
Winter, M. G., Hughes, E. R., Muramatsu, M. K., Jimenez, A. G., Chanin, R. B., Spiga, L., Gillis, C. C., McClelland, M., Andrews‐Polymenis, H. L., & Winter, S. (2023) · mBio · doi:10.1128/mbio.00921-23 · Cited by 18
Singh, S., & Koo, O. K. (2024) · Pathogens · doi:10.3390/pathogens13080642 · Cited by 19
“…peptides called microcins M and H47, which are absorbed by salmochelin uptake After the salmochelin uptake systems absorb the salmochelin derivatives conjugated to antimicrobial peptides, they can effectively target and inhibit the growth of Salmonella bacteria in the gut. systems [25,26].”
Shastri, M. D., Chong, W. C., Vemuri, R., Martoni, C., Adhikari, S., Bhullar, H., Kunde, D., Tristram, S. G., & Eri, R. D. (2020) · Microorganisms · doi:10.3390/microorganisms8111758 · Cited by 17
“It has been proposed that probiotics can restore the intestinal tract homeostasis either by disrupting pathogen signaling via the inhibition of quorum sensing [26], production of antimicrobial compounds that can inhibit pathogens [27], improving mucosal integrity against pathogens [28], or by competing for and reducin…”
BackgroundDhusia, K., Bajpai, A., & Ramteke, P. W. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.001 · Cited by 16
RetractedSarichai, P., Buddhasiri, S., Walters, G. E., Khantawa, B., Kaewsakhorn, T., Chantarasakha, K., Tepaamorndech, S., & Thiennimitr, P. (2020) · Microbiology and Immunology · doi:10.1111/1348-0421.12837 · Cited by 19
Mechanisms conferring multi-layered protection against intestinal Salmonella Typhimurium infection
Kroon, S., & Hardt, W. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf038 · Cited by 17
“The microbiota produces bacteriocins that act as toxins primarily on closely related species, limiting the ability of these species to colonise the gut lumen (Kommineni et al. 2015 ; Sassone-Corsi et al. 2016 ).”
Current research status and trends in the bioactivity of postbiotics
Chen, X., Yuan, C., He, J., Li, W., & Liao, C. (2025) · Frontiers in Food Science and Technology · doi:10.3389/frfst.2025.1692683 · Cited by 18
Xu, H., Hou, Q., Zhu, J., Feng, M., Wang, P., & Pan, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120330 · Cited by 14
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective
Zhang, H., Wu, J., Li, N., Wu, R., & Chen, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188989 · Cited by 15
Metadata
- Authors
- Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Raffatellu, Manuela
- Venue
- Nature
- Published
- 2016-10-31
- Volume
- 540
- Issue
- 7632
- Pages
- 280-283
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5145735
- OpenAlex
- W2545187638
- Cited by
- 549
- References
- 29
- Citations by year
- 2026: 40 · 2025: 64 · 2024: 63 · 2023: 56 · 2022: 75 · 2021: 61 · 2020: 60 · 2019: 54 · 2018: 38 · 2017: 36 · 2016: 1
- FWCI
- 54.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI114625, R01AI083663, R56AI114625, R01AI126277, R21AI105374, R21AI101784, R37AI126277)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058057)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- microcin, Enterobacteriaceae, intestinal inflammation, interspecific competition, intraspecific competition, Escherichia coli Nissle 1917, probiotics, dysbiosis, Salmonella enterica, adherent-invasive Escherichia coli, antimicrobial peptides, intestinal colonization, gut microbiota
- MeSH terms
- Animals, Bacteriocins, Enterobacteriaceae, Escherichia coli, Female, Inflammation, Intestinal Mucosa, Intestines, Male, Mice, Inbred C57BL, Symbiosis, Salmonella enterica, Probiotics, Mice, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.